Simvastatin-Fluvastatin Comparative Study

Illingworth DR, Stein E, Knopp R, et al. A randomised multi-center trial comparing the efficacy of simvastatin and fluvastatin. J Cardiovasc Pharmacol Ther 1996; 1: 23–30 Jacotot B, Benghozi R, Pfister P, et al. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. Am J Cardiol 1995; 76: 54–56A Findley Walker J. HMG CoA reductase inhibitors. Current clinical experience. Drugs 1988; 36: 83–86 Deslypere JP. The role of HMG CoA reductase inhibitors in the treatment of hyperlipidemia: a review of fluvastatin. Cur Ther Res 1995; 56: 111–28 Illingworth D. Unpublished results 1993 Ose L, Scott R, and the Simvastatin — Fluvastatin Study Group. Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolemia. Clin Drug Invest 1995; 10: 127–38 Illingworth DR, Stein EA, Knopp RH, et al. A randomized multicenter trial comparing the efficacy of simvastatin and fluvastatin. J Cardiovasc Pharmacol Ther 1996; 1: 23–30 Berger ML, Wilson HM, Liss CL. A comparison of the tolerability and efficacy of lovastatin 20mg and fluvastatin 20mg in the treatment of primary hypercholesterolemia. J Cardiovasc Pharmacol Ther. In press Illingworth DR, Tobert JA. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin Ther 1994; 16: 366–85 Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367–72 The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9